Brett K. Haumann

Biography

 Brett K. Haumann, M.D., M.B.A., joined Theravance Biopharma in June 2014 in connection with our spin‑off from Theravance, Inc., after joining Theravance, Inc. as Vice President, Clinical Development in October 2013. He became Vice President, Clinical Development and Operations of Theravance, Inc. in March 2014 and became Senior Vice President, Clinical Development at Theravance Biopharma in December 2014. Prior to joining Theravance, Inc., Dr. Haumann served as Chief Medical Officer at Circassia Limited. Previously, Dr. Haumann held senior positions at GlaxoSmithKline, including Medicines Development Leader and Vice President Clinical Development. Dr. Haumann has more than 15 years of experience in the discovery and development of pulmonary and allergy medicines. Dr. Haumann completed his M.D. at the University of Witwatersrand Medical School, South Africa and holds an M.B.A. from Open University, United Kingdom.

Research Interest

 Vice President Clinical Development